Wikidata

(Q54535188)

English

The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.

scientific article

In more languages

Statements

title
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22261800
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22261800
main subject
patient
0 references
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54535188&oldid=1647045413"